Hong Kong's regulatory reforms mostly welcomed by pharma
This article was originally published in Scrip
Executive Summary
The pharmaceutical industry in Hong Kong has generally welcomed a set of far-reaching recommendations to come out of an official review of pharmaceutical regulation in the territory, although it has lingering concerns about their full implementation.